Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C

被引:52
|
作者
Zell, R
Sidigi, K
Bucci, E
Stelzner, A
Görlach, M
机构
[1] Klinikum Univ Jena, Inst Virol, D-07745 Jena, Germany
[2] Ctr Studio Biocristallog, I-80134 Naples, Italy
[3] Inst Mol Biotechnol, NMR Spekroskopie, Abt Mol Biophys, D-07745 Jena, Germany
关键词
CD spectroscopy; enterovirus replication; picornavirus; replication initiation; RNA secondary structures;
D O I
10.1017/S1355838202012785
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The initiation of enteroviral positive-strand RNA synthesis requires the presence of a functional ribonucleoprotein complex containing a cloverleaf-like RNA secondary structure at the 5' end of the viral genome. Other components of the ribonucleoprotein complex are the viral 3CD proteinase (the precursor protein of the 3C proteinase and the 3D polymerase), the viral 3AB protein and the cellular poly(rC)-binding protein 2. For a molecular characterization of the RNA-binding properties of the enteroviral proteinase, the 3C proteinase of coxsackievirus B3 (CVB3) was bacterially expressed and purified. The recombinant protein is proteolytically active and forms a stable complex with in vitro-transcribed cloverleaf RNA of CVB3. The formation of stable complexes is also demonstrated with cloverleaf RNA of poliovirus (PV) 1, the first cloverleaf of bovine enterovirus (BEV) 1, and human rhinovirus (HRV) 2 but not with cloverleaf RNA of HRV14 and the second cloverleaf of BEV1. The apparent dissociation constants of the protein:RNA complexes range from approx. 1.7 to 4.6 muM. An electrophoretic mobility shift assay with subdomain D of the CVB3 cloverleaf demonstrates that this RNA is sufficient to bind the CVB3 3C proteinase. Binding assays using mutated versions of CVB3 and HRV14 cloverleaf RNAs suggest that the presence of structural features rather than a defined sequence motif of loop D are important for 3C proteinase-RNA interaction.
引用
收藏
页码:188 / 201
页数:14
相关论文
共 50 条
  • [1] The structure of the stemloop D subdomain of coxsackievirus B3 cloverleaf RNA and its interaction with the proteinase 3C
    Ohlenschläger, O
    Wöhnert, J
    Bucci, E
    Seitz, S
    Häfner, S
    Ramachandran, R
    Zell, R
    Görlach, M
    [J]. STRUCTURE, 2004, 12 (02) : 237 - 248
  • [2] MUTATIONAL ANALYSIS OF THE PUTATIVE SUBSTRATE-BINDING SITE OF 3C PROTEINASE OF COXSACKIEVIRUS B3
    MIYASHITA, K
    UTSUMI, R
    UTSUMI, T
    KOMANO, T
    SATOH, N
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1995, 59 (01) : 121 - 122
  • [3] Antiviral Activity of Coxsackievirus B3 3C Protease Inhibitor
    Yun, Soo-Hyeon
    Song, Hyun-Mi
    Ju, Eun-Seon
    Lim, Byung-Kwan
    Jeong, Jin-Ok
    Kim, Sung Hae
    Park, Woo Jin
    Jeon, Eun-Seok
    [J]. CIRCULATION, 2008, 118 (18) : S282 - S282
  • [4] Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease
    Kim, Bo-Kyoung
    Kwak, Seung-Hwa
    Jung, Young-Hwan
    Kim, Tae-Kyun
    Son, Borum
    Park, Ji Yeon
    Choi, Soo-Jeong
    Kim, Jeong-Hyun
    Cho, Joong-Heui
    Jeong, Pyeonghwa
    Kim, Yong-Chul
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [5] Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease
    Kim, Bo-Kyoung
    Cho, Joong-Heui
    Jeong, Pyeonghwa
    Lee, Youngjin
    Lim, Jia Jia
    Park, Kyoung Ryoung
    Eom, Soo Hyun
    Kim, Yong-Chul
    [J]. FEBS LETTERS, 2015, 589 (15) : 1795 - 1801
  • [6] Soluble Coxsackievirus B3 3C Protease Inhibitor Prevent Enteroviral-Mediated Cardiomyopathy in Experimental Chronic Murine Myocarditis Model
    Lim, Byung-kwan
    Yun, Soo-Hyeon
    Ju, Eun-Seon
    Chang, Song-A
    Lee, Yoo-Jung
    Choi, Jn-Oh
    Kim, Young-Chui
    Jeon, Eun-Seok
    [J]. CIRCULATION, 2012, 126 (21)
  • [7] Genetic determinants of coxsackievirus B3 pathogenesis
    McManus, BM
    Yanagawa, B
    Rezai, N
    Luo, HL
    Taylor, L
    Zhang, M
    Yuan, J
    Buckley, J
    Triche, T
    Schreiner, G
    Yang, DC
    [J]. MICROARRAYS, IMMUNE RESPONSES AND VACCINES, 2002, 975 : 169 - 179
  • [8] Antiviral Activity of Water Soluble Coxsackievirus B3 3C Protease Inhibitor
    Jeon, Eun-Seok
    Yun, Soo-Hyeon
    Choi, Jin-Oh
    Ju, Eun-Seon
    Kirn, Yong-Chul
    [J]. JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S65 - S65
  • [9] Coxsackievirus B3 protease 3C: expression, purification, crystallization and preliminary structural insights
    Fili, Stavroula
    Valmas, Alexandros
    Christopoulou, Magdalini
    Spiliopoulou, Maria
    Nikolopoulos, Nikos
    Lichiere, Julie
    Logotheti, Souzana
    Karavassili, Fotini
    Rosmaraki, Eleftheria
    Fitch, Andrew
    Wright, Jonathan
    Beckers, Detlef
    Degen, Thomas
    Nenert, Gwilherm
    Hilgenfeld, Rolf
    Papageorgiou, Nicolas
    Canard, Bruno
    Coutard, Bruno
    Margiolaki, Irene
    [J]. ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2016, 72 : 877 - 884
  • [10] Antiviral Activity of Coxsackievirus B3 3C Protease Inhibitor in Experimental Murine Myocarditis
    Yun, Soo-Hyeon
    Lee, Won Gil
    Kim, Yong-Chul
    Ju, Eun-Seon
    Lim, Byung-Kwan
    Choi, Jin-Oh
    Kim, Duk-Kyung
    Jeon, Eun-Seok
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (03): : 491 - 497